These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 9821805

  • 1. Effect of herbimycin A on tyrosine kinase receptors and platelet derived growth factor (PDGF)-induced signal transduction.
    Murakami Y, Fukazawa H, Mizuno S, Uehara Y.
    Biol Pharm Bull; 1998 Oct; 21(10):1030-5. PubMed ID: 9821805
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of PDGF-induced phospholipase D but not phospholipase C activation by herbimycin A.
    Kim BY, Ahn SC, Oh HK, Lee HS, Mheen TI, Rho HM, Ahn JS.
    Biochem Biophys Res Commun; 1995 Jul 26; 212(3):1061-7. PubMed ID: 7626093
    [Abstract] [Full Text] [Related]

  • 3. A dual inhibitor of platelet-derived growth factor beta-receptor and Src kinase activity potently interferes with motogenic and mitogenic responses to PDGF in vascular smooth muscle cells. A novel candidate for prevention of vascular remodeling.
    Waltenberger J, Uecker A, Kroll J, Frank H, Mayr U, Bjorge JD, Fujita D, Gazit A, Hombach V, Levitzki A, Böhmer FD.
    Circ Res; 1999 Jul 09; 85(1):12-22. PubMed ID: 10400906
    [Abstract] [Full Text] [Related]

  • 4. Conversion of epidermal growth factor (EGF) into a stimulatory ligand for A431-cell growth by herbimycin A by decreasing the level of expression of EGF receptor.
    Murakami Y, Fukazawa H, Mizuno S, Uehara Y.
    Biochem J; 1994 Jul 01; 301 ( Pt 1)(Pt 1):57-62. PubMed ID: 8037691
    [Abstract] [Full Text] [Related]

  • 5. Pyrazolo pyrimidine-type inhibitors of SRC family tyrosine kinases promote ovarian steroid-induced differentiation of human endometrial stromal cells in vitro.
    Maruyama T, Yamamoto Y, Shimizu A, Masuda H, Sakai N, Sakurai R, Asada H, Yoshimura Y.
    Biol Reprod; 2004 Jan 01; 70(1):214-21. PubMed ID: 14522827
    [Abstract] [Full Text] [Related]

  • 6. Inhibition of PDGF-induced phospholipase C activation by herbimycin A.
    Kim BY, Ahn SC, Kang DO, Ko HR, Oh WK, Lee HS, Mheen TI, Rho HM, Ahn JS.
    Biochim Biophys Acta; 1996 Mar 27; 1311(1):33-6. PubMed ID: 8603100
    [Abstract] [Full Text] [Related]

  • 7. UCS15A, a non-kinase inhibitor of Src signal transduction.
    Sharma SV, Oneyama C, Yamashita Y, Nakano H, Sugawara K, Hamada M, Kosaka N, Tamaoki T.
    Oncogene; 2001 Apr 19; 20(17):2068-79. PubMed ID: 11360191
    [Abstract] [Full Text] [Related]

  • 8. Involvement of tyrosine phosphorylation and protein kinase C in the activation of phospholipase D by H2O2 in Swiss 3T3 fibroblasts.
    Min DS, Kim EG, Exton JH.
    J Biol Chem; 1998 Nov 06; 273(45):29986-94. PubMed ID: 9792719
    [Abstract] [Full Text] [Related]

  • 9. Selective inhibition of platelet-derived growth factor (PDGF) receptor autophosphorylation and PDGF-mediated cellular events by a quinoline derivative.
    Yagi M, Kato S, Kobayashi Y, Kubo K, Oyama S, Shimizu T, Nishitoba T, Isoe T, Nakamura K, Ohashi H, Kobayashi N, Iinuma N, Osawa T, Onose R, Osada H.
    Exp Cell Res; 1997 Aug 01; 234(2):285-92. PubMed ID: 9260896
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of platelet-derived growth factor-mediated signal transduction and tumor growth by N-[4-(trifluoromethyl)-phenyl]5-methylisoxazole-4-carboxamide.
    Shawver LK, Schwartz DP, Mann E, Chen H, Tsai J, Chu L, Taylorson L, Longhi M, Meredith S, Germain L, Jacobs JS, Tang C, Ullrich A, Berens ME, Hersh E, McMahon G, Hirth KP, Powell TJ.
    Clin Cancer Res; 1997 Jul 01; 3(7):1167-77. PubMed ID: 9815796
    [Abstract] [Full Text] [Related]

  • 11. Divergence in signal transduction pathways of platelet-derived growth factor (PDGF) and epidermal growth factor (EGF) receptors. Involvement of sphingosine 1-phosphate in PDGF but not EGF signaling.
    Rani CS, Wang F, Fuior E, Berger A, Wu J, Sturgill TW, Beitner-Johnson D, LeRoith D, Varticovski L, Spiegel S.
    J Biol Chem; 1997 Apr 18; 272(16):10777-83. PubMed ID: 9099730
    [Abstract] [Full Text] [Related]

  • 12. Inhibition of platelet-derived growth factor and epidermal growth factor receptor signaling events after treatment of cells with specific synthetic inhibitors of tyrosine kinase phosphorylation.
    Lipson KE, Pang L, Huber LJ, Chen H, Tsai JM, Hirth P, Gazit A, Levitzki A, McMahon G.
    J Pharmacol Exp Ther; 1998 May 18; 285(2):844-52. PubMed ID: 9580635
    [Abstract] [Full Text] [Related]

  • 13. c-Jun N-terminal kinase activation by hydrogen peroxide in endothelial cells involves SRC-dependent epidermal growth factor receptor transactivation.
    Chen K, Vita JA, Berk BC, Keaney JF.
    J Biol Chem; 2001 May 11; 276(19):16045-50. PubMed ID: 11278982
    [Abstract] [Full Text] [Related]

  • 14. Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway.
    Clark JW, Santos-Moore A, Stevenson LE, Frackelton AR.
    Int J Cancer; 1996 Jan 17; 65(2):186-91. PubMed ID: 8567115
    [Abstract] [Full Text] [Related]

  • 15. PDGF-BB-mediated activation of p42(MAPK) is independent of PDGF beta-receptor tyrosine phosphorylation.
    Cartel NJ, Liu J, Wang J, Post M.
    Am J Physiol Lung Cell Mol Physiol; 2001 Oct 17; 281(4):L786-98. PubMed ID: 11557582
    [Abstract] [Full Text] [Related]

  • 16. Accelerated degradation of 160 kDa epidermal growth factor (EGF) receptor precursor by the tyrosine kinase inhibitor herbimycin A in the endoplasmic reticulum of A431 human epidermoid carcinoma cells.
    Murakami Y, Mizuno S, Uehara Y.
    Biochem J; 1994 Jul 01; 301 ( Pt 1)(Pt 1):63-8. PubMed ID: 8037692
    [Abstract] [Full Text] [Related]

  • 17. Tyrosine kinase inhibitors inhibit multiple steps of the cell cycle of vascular smooth muscle cells.
    Shimokado K, Umezawa K, Ogata J.
    Exp Cell Res; 1995 Oct 01; 220(2):266-73. PubMed ID: 7556433
    [Abstract] [Full Text] [Related]

  • 18. The protein tyrosine kinase inhibitor herbimycin A, but not genistein, specifically inhibits signal transduction by the T cell antigen receptor.
    Graber M, June CH, Samelson LE, Weiss A.
    Int Immunol; 1992 Nov 01; 4(11):1201-10. PubMed ID: 1472473
    [Abstract] [Full Text] [Related]

  • 19. Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.
    Buchdunger E, Zimmermann J, Mett H, Meyer T, Müller M, Regenass U, Lydon NB.
    Proc Natl Acad Sci U S A; 1995 Mar 28; 92(7):2558-62. PubMed ID: 7708684
    [Abstract] [Full Text] [Related]

  • 20. Benzoquinoid ansamycins (herbimycin A and geldanamycin) interfere with the maturation of growth factor receptor tyrosine kinases.
    Sakagami M, Morrison P, Welch WJ.
    Cell Stress Chaperones; 1999 Mar 28; 4(1):19-28. PubMed ID: 10467105
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.